在临床常规中,Ruxolitinib用于治疗骨髓纤维化的大型非干预性第四期研究的最终结果
Steffen Koschmieder1,2, Susanne Isfort1,2,3, Clemens Schulte4
1Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
European journal of haematology
|July 7, 2025
概括
该JAKoMo研究发现,现实世界中的 ruxolitinib (RUX) 治疗显著提高了骨髓纤维化 (MF) 患者的疗效和生活质量. 益处持续了36个月,不良事件比临床试验少.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 骨髓纤维化 (MF) 是一种严重的骨髓疾病.
- 卢克索利提尼布 (RUX) 是一种已批准的MF治疗方法,但对其长期影响的真实数据很重要.
- 该JAKoMo研究提供了关于RUX在德国常规临床实践中的使用的见解.
研究的目的:
- 评估 ruxolitinib (RUX) 在肌肉纤维化 (MF) 患者的实际疗效,安全性和生活质量 (QOL).
- 为了比较RUX-naïve患者与之前接受RUX治疗的患者的结局.
- 在一个大型的多中心队列中评估RUX的长期 (36个月) 影响.
主要方法:
- 在德国122个中心对943名多发性肺炎患者进行了非干预性多中心研究.
- 患者年龄≥18岁,患有原发性MF,多细胞血症后的MF,或MF后的基本血小板血.
- 患者被分为RUX-naïve (Arm A) 或RUX-experienced (Arm B) 的类别,并进行了36个月的随访.
主要成果:
- 之前没有使用RUX的患者 (A组) 在6个月内显示出有效性和QOL的快速和持续改善.
- 两只手臂的患者报告QOL正常的患者增加了~17%.
- 与注册试验相比,不良事件的发生率较低,可能是由于个性化剂量.
结论:
- 在MF患者的现实世界RUX治疗带来了显著和持续的临床益处,并改善了QOL.
- 改善包括一般健康状况和减少MF相关的疲劳.
- 持续的反应和较少的不良事件表明,个性化剂量策略在现实环境中是有效的.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275


